- Home
- CRNC vs LENZ Comparison
CRNC vs LENZ Comparison
Compare CRNC & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRNC | LENZ |
|---|---|---|
| Founded | 2020 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 382.7M | 310.4M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRNC | LENZ |
|---|---|---|
| Price | $8.98 | $9.97 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $10.25 | ★ $45.60 |
| AVG Volume (30 Days) | 637.1K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.95 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $251,781,000.00 | $19,088,000.00 |
| Revenue This Year | $27.18 | $51.35 |
| Revenue Next Year | N/A | $198.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.85 | $8.25 |
| 52 Week High | $13.74 | $50.19 |
Technical Indicators
Market Signals| Indicator | CRNC | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 70.71 | 47.63 |
| Support Level | $8.83 | $8.99 |
| Resistance Level | $10.06 | $10.29 |
| Average True Range (ATR) | 0.42 | 0.68 |
| MACD | 0.25 | 0.25 |
| Stochastic Oscillator | 99.50 | 87.82 |
Price Performance
Historical ComparisonAbout CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.